Til hovedinnhold
Norli Bokhandel

Formulating Poorly Water Soluble Drugs

2022, Innbundet, Engelsk

2 599,-

Bestillingsvare – sendes normalt innen 10-14 virkedager
  • Ikke tilgjengelig for hent i butikk
The objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist’s approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound’s physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at a minimum a working knowledge of each of the above mentioned facetsand detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.

Produktegenskaper

  • Bidragsyter

    Daniel A. Davis Jr. (Redaktør) ; Robert O. Williams III (Redaktør) ; Dave A. Miller (Redaktør)
  • Forlag/utgiver

    Springer Nature Switzerland AG
  • Format

    Innbundet
  • Språk

    Engelsk
  • Utgivelsesår

    2022
  • Antall sider

    693
  • Serienavn

    AAPS Advances in the Pharmaceutical Sciences Series
  • Utgivelsesdato

    20.05.2022
  • Varenummer

    9783030887186

Kundeanmeldelser

Frakt og levering